TABLE 2
FROM:
Keratin expression in schwannoma; a study of 115 retroperitoneal and 22 peripheral schwannomas
Julie C Fanburg-Smith, Mourad Majidi and Markku Miettinen
BACK TO ARTICLETable 2. Retroperitoneal schwannoma immunostain results, summarized
| Antibody | Number positive/number stained | Percentage positive (%) |
|---|---|---|
| S100 protein | 90/90 | 100 |
| GFAP | 104/115 | 90 |
| AE1/AE3 | 71/104 | 69 |
34 E12a
| 0/23a | 0 |
| CK1 | 24/39a | 62 |
| CK4 | 0/39a | 0 |
| CK5/6a | 0/11a | 0 |
| CK6 | 1/24a, b | 4 |
| CK7a | 8/61a, b | 13 |
| Cam 5.2 (CK8/18)a | 0/58a | 0 |
| CK10 | 0/24a | 0 |
| CK13 | 0/15a | 0 |
| CK14 | 3/24a, b | 13 |
| CK15 | 0/39a | 0 |
| CK16 | 0/39a | 0 |
| CK17 | 0/39a | 0 |
| CK18 | 0/24a | 0 |
| CK19a | 0/35a | 0 |
| CK20 | 0/24a | 0 |
a Only evaluated on AE1/AE3 positive-tumors.
b Difficult to separate from small vessel staining (myopericytic and smooth muscle cells) in highly vascular areas (Figure 5, Ref.11).

E12a